BGI Genomics Co Ltd
300676.SZ- Latest Trade
- trading lower70.91CNY
- Change
- -0.79
- % Change
1.10%Negative
- Day Range
- 70.50 - 71.60
- 52-Week Range
- 59.40 - 121.69
As of Jul 3 2022. Values delayed up to 15 minutes
- Previous Close
- 71.70
- Open
- 71.58
- Volume
- 3,824,632.00
- 3 Month Average Trading Volume
- 81.45
- Shares Out (Mil)
- 407.91
- Market Cap
- 29,350.66
- Forward P/E
- 26.86
- Dividend Yield
- 0.49
Key Statistics
2.5 mean rating - 2 analysts
- P/E Excl. Extra Items (TTM)
- 23.06
- Price To Sales (TTM)
- 4.43
- Price To Book (Quarterly)
- 3.11
- Price To Cash Flow (Per Share TTM)
- -99,999.99
- Total Debt/Total Equity (Quarterly)
- 9.03
- Long Term Debt/Equity (Quarterly)
- 0.78
- Return On Investment (TTM)
- 12.79
- Return On Equity (TTM)
- 9.51
2021 (millions USD)
About BGI Genomics Co Ltd
Company Information
BGI Genomics Co Ltd is a China-based company principally engaged in the diagnosis and research of genomics. The Company's main products and services include reproductive health basic research and clinical application services, basic science research services (genome sequencing, bioinformatics analysis and other multithreaded solutions), complex disease basic research and clinical application services, as well as drugs basic research and clinical application services. The Company mainly provides services for domestic and overseas academic institutions, research institutes, independent laboratories, pharmaceutical companies, hospitals and medical institutions, among others. The Company mainly operates its businesses in domestic market.
Address
Ole Maaloees Vej 3, Copenhagen NSHENZHEN, GNG
518083
China
Industry
Biotechnology & Drugs
Executive Leadership
- Jian Wang
- Chairman of the Board
- Ye Yin
- Vice Chairman of the Board
- Yujue Wang
- Chief Financial Officer
- Shoujiang Huo
- Chief Human Resource Officer
- Qian Xu
- General Counsel, Deputy General Manager, Secretary of the Board
- Lijian Zhao
- General Manager, Director
- Yutao Du
- Deputy General Manager, Director
- Hongqi Wang
- Deputy General Manager, Director
- Weijun Chen
- Deputy General Manager
- Ning Li
- Deputy General Manager
- Na Liu
- Deputy General Manager
- Shida Zhu
- Deputy General Manager
- Hongtao Wang
- Director
- Ya Cao
- Independent Director
- Lan Du
- Independent Director
Latest News
- WorldGermany taking seriously report on China's BGI collecting gene data - spokesman
Germany takes seriously a report that China's BGI Genomics is passing personal DNA data to Chinese authorities and is discussing the matter with the relevant Berlin ministries and the European Commission, a health ministry spokesperson said.
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,806.10 | 0.11%Positive |
| Copper | 679.40 | 2.12%Negative |
| Brent Crude Oil | 111.63 | -- |
| CBOT Soybeans | 1,622.00 | 3.16%Negative |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,825.33 | 1.06%Positive |
| Euro STOXX 50 | 3,448.31 | 0.19%Negative |
| FTSE 100 | 7,168.65 | 0.01%Negative |
| Nikkei 225 | 25,935.62 | 1.73%Negative |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes